Keywords: Innovative Medicines Initiative, IMI, Antibiotic development, Antimicrobial resistance, EFPIA, EU

IMI launches antimicrobial resistance projects to revitalize antibiotic development

Article | 11 February 2013

Europe’s Innovative Medicines Initiative yesterday launched two new projects through its antimicrobial resistance (AMR) program New Drugs for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in